查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679358

感染疾病分子诊断市场规模、份额、趋势分析报告：按产品、技术、应用、最终用途、地区和细分市场进行预测，2025 年至 2030 年

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

感染疾病分子诊断市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球感染疾病分子诊断市场规模预计到2030年将达到201.5亿美元，2025-2030年期间的复合年增长率为3.37%。

该市场受到技术先进产品的推出和 PoC 环境中对分子诊断日益增长的需求的推动。

便携性、准确的结果和成本效益等快速的技术进步预计将成为感染疾病分子诊断市场的主要驱动力。公司正在采用新技术并升级其产品以获得实际而精确的成果。主要企业正在透过开发针对新兴感染疾病的新型试剂套件来更新其 PCR 仪器产品系列，并透过与其他套件製造商达成协议来加强其研发倡议。

INAAT、质谱和 ISH 等技术非常先进，与其他传统诊断测试相比，假阳性率较低。该技术的成本效益、易用性和准确性等优势预计将增加该技术的采用。

分子诊断在研究实验室的应用正在增加。 PCR、 西方印渍术和 Southern blotting 等技术的使用正变得越来越普遍。此外，SARS-CoV-2 感染的全球蔓延导致诊断公司和政府增加了研究资金，以寻找创新的分子诊断方法。

分子诊断方法有效且能提供准确的结果。此外，这些测试可以早期发现疾病，从而降低替代威胁。然而，这些测试的高成本预计会促使患者转向外部替代方案。此外，SARS-CoV-2等新型感染疾病的检测具有较高的内部替代率，鼓励竞争公司之间形成敌对关係。

感染疾病分子诊断市场报告重点

  • 2024 年，试剂将以 25.86% 的收益占有率引领市场，并且由于其在感染疾病诊断中的广泛应用，预计在预测期内将以最快的复合年增长率增长。
  • 聚合酵素链锁反应(PCR) 技术广泛应用于检测包括 COVID-19、HIV、肝炎和结核病在内的感染疾病，在 2024 年占据了主导地位的收益占有率。
  • 2024 年，呼吸系统疾病占了最大的市场占有率，为 71.96%，这主要是由于呼吸道融合细胞病毒(RSV)、流感和 COVID-19 等呼吸道感染疾病的盛行率上升所致。
  • 目前，爱滋病毒、肝炎、结核病和呼吸道感染疾病等需要准确及时诊断的感染疾病疫情日益猖獗。
  • 北美感染疾病分子诊断市场受到 COVID-19、流感、HIV 和肝炎等感染疾病高流行的推动，占 2024 年收益占有率的 40.95%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章感染疾病分子诊断市场变数、趋势与范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 感染疾病分子诊断市场分析工具
    • 波特的分析
    • PESTEL 分析

第四章感染疾病分子诊断市场：按产品分類的估计和趋势分析

  • 细分仪表板
  • 感染疾病分子诊断市场：2024 年和 2030 年产品差异分析
  • 装置
  • 试剂
  • 服务

第五章感染疾病分子诊断市场：依技术、估计和趋势分析

  • 细分仪表板
  • 感染疾病分子诊断市场：2024 年与 2030 年技术变迁分析
  • 聚合酵素链锁反应（PCR）
    • 多重PCR
    • 其他PCR
  • 原位杂合反应
    • 装置
    • 试剂
    • 其他的
  • 恒温核酸增幅技术（INAAT）
    • 装置
    • 试剂
    • 其他的
  • 晶片和微阵列
    • 装置
    • 试剂
    • 其他的
  • 质谱法
    • 装置
    • 试剂
    • 其他的
  • 顺序
    • 装置
    • 试剂
    • 其他的
  • 转录扩增
    • 装置
    • 试剂
    • 其他的
  • 其他的
    • 装置
    • 试剂
    • 其他的

第六章感染疾病分子诊断市场：按应用的估计和趋势分析

  • 细分仪表板
  • 感染疾病分子诊断市场：2024年及2030年应用趋势分析
  • 呼吸系统疾病
  • 结核
  • 脑膜炎
  • 胃肠道感染疾病
  • HPV
  • 性行为感染传染病
  • 败血症
  • 抗药性疾病
  • 其他的

第七章感染疾病分子诊断市场：依最终用途的估计和趋势分析

  • 细分仪表板
  • 感染疾病分子诊断市场：2024 年和 2030 年最终用途趋势分析
  • 医院
  • 诊所
  • 诊断实验室
  • 研究所

第八章感染疾病分子诊断市场：按地区估计和趋势分析

  • 2024 年及 2030 年感染疾病分子诊断市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Abbott
    • Danaher Corporation
    • bioMerieux SA
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Hologic, Inc.（Gen-Probe）
    • Grifols SA
    • Qiagen
    • Siemens Healthineers AG
    • Sysmex Corporation
Product Code: GVR-4-68039-529-7

Infectious Disease Molecular Diagnostics Market Growth & Trends:

The global infectious disease molecular diagnostics market size is expected to reach USD 20.15 billion by 2030, registering a CAGR of 3.37% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings.

Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies.

Technologies such as INAAT, mass spectroscopy, and ISH are advanced and have a low false-positive rate as compared to other traditional diagnostic tests. Advantages such as the cost-effectiveness and user-friendliness of this technology and the accuracy offered are estimated to increase the adoption of this technology.

The use of molecular diagnostics in research institutes is increasing. The use of techniques such as PCR, western blotting, and southern blotting is becoming common. Moreover, the spread of SARS-CoV-2 infection globally has led to an increase in research funding by governments as well as diagnostic companies to search for innovative molecular diagnostics.

Molecular diagnostics deliver effective and accurate results. Moreover, these tests enable the early detection of diseases, maintaining a low threat of substitutes. However, the high prices of these tests are expected to encourage patients to shift to external substitutes. Moreover, for the detection of newer infections such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry.

Infectious Disease Molecular Diagnostics Market Report Highlights:

  • Reagents led the market with a 25.86% revenue share in 2024 and are projected to experience the fastest CAGR over the forecast period due to their widespread use in infectious disease diagnostics.
  • Polymerase Chain Reaction (PCR) technology secured the dominant revenue share in 2024 owing to its widespread application in detecting a broad range of infectious diseases, including COVID-19, HIV, hepatitis, and tuberculosis.
  • Respiratory diseases held the largest market share of 71.96% in 2024, driven primarily by the rising prevalence of respiratory infectious diseases such as Respiratory Syncytial Virus (RSV), influenza, COVID-19, etc.
  • Diagnostic laboratories held the dominant revenue share in 2024, driven by the rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and respiratory infections, which require accurate and timely diagnosis.
  • North America infectious disease molecular diagnosis market accounted for 40.95% of the revenue share in 2024, driven by the high prevalence of infectious diseases such as COVID-19, influenza, HIV, and hepatitis.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Infectious Disease Molecular Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Infectious Disease Molecular Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Infectious Disease Molecular Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infectious Disease Molecular Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infectious Disease Molecular Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Polymerase Chain Reaction (PCR)
    • 5.3.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Multiplex PCR
      • 5.3.2.1. Multiplex PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.2. Instruments
        • 5.3.2.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.3. Reagents
        • 5.3.2.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.4. Others
        • 5.3.2.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Other PCR
        • 5.3.3.1.1. Other PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. In Situ Hybridization
    • 5.4.1. In Situ Hybridization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 5.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Chips and Microarrays
    • 5.6.1. Chips and Microarrays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Mass Spectrometry
    • 5.7.1. Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. Others
      • 5.7.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Sequencing
    • 5.8.1. Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. Others
      • 5.8.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Transcription Mediated Amplification
    • 5.9.1. Transcription Mediated Amplification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. Others
      • 5.9.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.10.2. Instruments
      • 5.10.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.10.3. Reagents
      • 5.10.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.10.4. Others
      • 5.10.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infectious Disease Molecular Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Infectious Disease Molecular Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Respiratory Diseases
    • 6.3.1. Respiratory Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Tuberculosis
    • 6.4.1. Tuberculosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Meningitis
    • 6.5.1. Meningitis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Gastrointestinal Tract Infections
    • 6.6.1. Gastrointestinal Tract Infections Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. HPV
    • 6.7.1. HPV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Sexually Transmitted Infections
    • 6.8.1. Sexually Transmitted Infections Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Sepsis
    • 6.9.1. Sepsis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Drug Resistance Diseases
    • 6.10.1. Drug Resistance Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Infectious Disease Molecular Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Infectious Disease Molecular Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Diagnostics Laboratories
    • 7.5.1. Diagnostics Laboratories Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Research Institutes
    • 7.6.1. Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Infectious Disease Molecular Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Infectious Disease Molecular Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Abbott
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Danaher Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. bioMerieux SA
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. F. Hoffmann-La Roche Ltd
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Bio-Rad Laboratories, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Agilent Technologies, Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Becton, Dickinson and Company
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Hologic, Inc. (Gen-Probe)
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Grifols S.A.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Qiagen
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives
    • 9.4.11. Siemens Healthineers AG
      • 9.4.11.1. Participant's Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Recent Developments/ Strategic Initiatives
    • 9.4.12. Sysmex Corporation
      • 9.4.12.1. Participant's Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global infectious disease molecular diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 North America infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 12 U.S. infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Mexico infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29 UK infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Germany infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Germany infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 France infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 France infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 France infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Italy infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Spain infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Norway infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Norway infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Japan infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 70 China infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 China infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 72 China infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 73 China infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 75 India infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 India infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 India infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Australia infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Korea infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Korea infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Korea infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Thailand infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Thailand infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Latin America infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Brazil infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 99 Argentina infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 103 MEA infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 108 South Africa infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 116 UAE infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Infectious disease molecular diagnostics market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Infectious disease molecular diagnostics market: Product outlook key takeaways
  • Fig. 20 Infectious disease molecular diagnostics market: Product movement analysis
  • Fig. 21 Transfemoral market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Infectious disease molecular diagnostics market: Technology outlook key takeaways
  • Fig. 26 Infectious disease molecular diagnostics market: Technology movement analysis
  • Fig. 27 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 In Situ Hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Chips and Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mass Spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Transcription Mediated Amplification market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Multiplex PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Other PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Infectious disease molecular diagnostics market: Application outlook key takeaways
  • Fig. 58 Infectious disease molecular diagnostics market: Application movement analysis
  • Fig. 59 Respiratory Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Tuberculosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Meningitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Gastrointestinal Tract Infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 HPV market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Sexually Transmitted Infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Sepsis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Drug Resistance Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Infectious disease molecular diagnostics market: End use outlook key takeaways
  • Fig. 69 Infectious disease molecular diagnostics market: End use movement analysis
  • Fig. 70 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Diagnostics Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 75 Regional marketplace: Key takeaways
  • Fig. 76 North America infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 U.S. infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Canada infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Mexico infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Europe infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 UK infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Germany infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 France infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Spain infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Italy infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Denmark infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Sweden infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Norway infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Asia Pacific infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Japan infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 China infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 India infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Australia infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 South Korea infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Thailand infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Market participant categorization
  • Fig. 115 Infectious disease molecular diagnostics market position analysis, 2023
  • Fig. 116 Strategic framework